4.7 Review

Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 145, 期 -, 页码 18-39

出版社

ELSEVIER
DOI: 10.1016/j.addr.2018.06.018

关键词

Antibiotic resistance; Animal models; Bacteriophage; Bacteriophage therapy; Biofilm; Clinical treatment

向作者/读者索取更多资源

Viruses of bacteria - known as bacteriophages or phages - have been used clinically as antibacterial agents for nearly 100 years. Often this phage therapy is of long-standing, persistent, or chronic bacterial infections, and this can be particularly so given prior but insufficiently effective infection treatment using standard antibiotics. Such infections, in turn, often have a biofilm component. Phages in modern medicine thus are envisaged to serve especially as anti-biofilm/anti-persistent infection agents. Here I review the English-language literature concerning in vivo experimental and clinical phage treatment of longer-lived bacterial infections. Overall, published data appears to be supportive of a relatively high potential for phages to cure infections which are long standing and which otherwise have resisted treatment with antibieiotics. (C) 2019 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据